miR-100, a downregulated miRNA in PC tissues and cell lines, could increase DDP sensitivity and suppress tumor growth in vivo via targeting fibroblast growth factor receptor 3 (FGFR3) (Li et al., 2014). Here, FGFR3 is linked to neoplasm.